Trial intelligence / Profile preview

Alizapride vs ondansetron for prevention of postoperative nausea and vomiting

2008-004789-20Phase 4Completed

Sponsor
UZ Leuven
Start
Jul 2008
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in postoperative nausea and vomiting (PONV) comparing Alizapride (Litican), Ondansetron (Zofran) and Placebo (3 arms). Primary endpoint: Total postoperative nausea and vomiting. Started Jul 2008; status: completed.

02

Drugs

alizaprideondansetron
03

Conditions

postoperative nausea and vomiting (PONV)

Beyond the preview

Go deeper on 2008-004789-20.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2008-004789-20.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call